Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: Systematic review

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Stevens, Adrienne ^a   Shamseer, Larissa ^a,b   Weinstein, Erica ^c   Yazdi, Fatemeh ^a   Turner, Lucy ^a   Thielman, Justin ^a   Altman, Douglas G ^d   Hirst, Allison ^d   Hoey, John ^e   Palepu, Anita ^f,g   Schulz, Kenneth F ^h   Moher, David ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e QUEEN S UNIVERSITY   (Canada)

^f ST PAUL S HOSPITAL   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLETENESS OF REPORTING; CONSENSUS DEVELOPMENT; ENGLISH AS A SECOND LANGUAGE; EVALUATION RESEARCH; FRENCH LANGUAGE; HEALTH IMPACT ASSESSMENT; HUMAN; LANGUAGE; MANDATORY REPORTING; MEDICAL RESEARCH; PEER REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SCIENTIFIC LITERATURE; SYSTEMATIC REVIEW; VALIDATION STUDY;

GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HEALTH SERVICES RESEARCH; HUMANS; PERIODICALS AS TOPIC; PUBLISHING; RESEARCH REPORT;

EID: 84903292570     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3804     Document Type: Review

References (162)

1. Chan AW, Altman DG. Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 2005;365:1159-62. (Pubitemid 40417566)
2. Chan S, Bhandari M. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. J Bone Joint Surg Am 2007;89:1970-8. (Pubitemid 350195028)
3. Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007;4:447-55. (Pubitemid 46495312)
4. Smith BA, Lee HJ, Lee JH, Choi M, Jones DE, Bausell RB, et al. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). Nurs Outlook 2008;56(1):31-7.
5. Yesupriya A, Evangelou E, Kavvoura FK, Patsopoulos NA, Clyne M, Walsh MC, et al. Reporting of Human Genome Epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol 2008;8.
6. Zhang D, Yin P, Freemantle N, Jordan R, Zhong N, Cheng KK. An assessment of the quality of randomised controlled trials conducted in China. Trials 2008;9:22.
7. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 2014;383:267-76.
8. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7(2).
9. Moher D, Weeks L, Ocampo M, Seely D, Sampson M, Altman DG, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epidemiol 2011;64:718-42.
10. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4.
11. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637-9. (Pubitemid 26278070)
12. Moher D, Schulz KF, Altman DG, Lepage L. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 2001;1:1-7. (Pubitemid 38904564)
13. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94. (Pubitemid 32322245)
14. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
15. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c869.
16. Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012;11:MR000030.
17. Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012;1:60.
18. Shamseer L, Stevens A, Skidmore B, Turner LA, Altman DG, Hirst A, et al. Does journal endorsement of reporting guidelines influence the completeness of reporting of health research? A systematic review protocol. Syst Rev 2012;1:24.
19. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
20. Review Manager [computer program]. Version 5.2. The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. Available at http://tech.cochrane.org/ revman.
21. Comprehensive Meta Analysis [computer program]. Version 2.2. BioStat, 2013.
22. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von EE, et al. STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009;6:e22.
23. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the arrive guidelines for reporting animal research. PloS Biol 2010;8:e1000412.
24. Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three Rs, and to make systematic reviews more feasible. Altern Lab Anim 2010;38:167-82.
25. Stock-Schroer B, Albrecht H, Betti L, Endler PC, Linde K, Ludtke R, et al. Reporting experiments in homeopathic basic research (REHBaR) - a detailed guideline for authors. Homeopathy 2009;98:287-98.
26. Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards IR, Fernandez AM, et al. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf 2007;16:581-7. (Pubitemid 46824280)
27. Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report - Part I. Value Health 2009;12:1044-52.
28. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003;49:1-6. (Pubitemid 36078546)
29. Bruns DE, Huth EJ, Magid E, Young DS. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 2000;46:893-5. (Pubitemid 30461256)
30. Donahue SP, Arnold RW, Ruben JB. Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies. J AAPOS 2003;7:314-6. (Pubitemid 37229993)
31. Gardner IA, Nielsen SS, Whittington RJ, Collins MT, Bakker D, Harris B, et al. Consensus-based reporting standards for diagnostic test accuracy studies for paratuberculosis in ruminants. Prev Vet Med 2011;101(1-2):18-34.
32. Drummond MF, Jefferson TO, for the BMJ Economic Evaluation Working Party. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275-83. (Pubitemid 26254740)
33. Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521-33. (Pubitemid 41727304)
34. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses: Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339-41. (Pubitemid 26346934)
35. Davis JC, Robertson MC, Comans T, Scuffham PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int 2011;22:2449-59.
36. Nicholson A, Berger K, Bohn R, Carcao M, Fischer K, Gringeri A, et al. Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of the International Prophylaxis Study Group. Haemophilia 2008;14:127-32.
37. Talmon J, Ammenwerth E, Brender J, de Keizer N, Nykanen P, Rigby M. STARE-HI-Statement on reporting of evaluation studies in Health Informatics. Int J Med Inf 2009;78:1-9.
38. Robinson TN, Patrick K, Eng TR, Gustafson D. An evidence-based approach to interactive health communication: a challenge to medicine in the information age. JAMA 1998;280:1264-9. (Pubitemid 28469234)
39. Brown P, Brunnhuber K, Chalkidou K, Chalmers I, Clarke M, Fenton M, et al. How to formulate research recommendations. BMJ 2006;333:804-6. (Pubitemid 44583363)
40. Rochon PA, Hoey J, Chan AW, Ferris LE, Lexchin J, Kalkar SR, et al. Financial Conflicts of Interest Checklist 2010 for clinical research studies. Open Med 2010;4:e69-91.
41. Research Information Network. Acknowledgement of funders in scholarly journal articles: guidance for UK research funders, authors and publishers. 2008. www.rin.ac.uk/system/files/attachments/Acknowledgement-funders-guidance. pdf.
42. Graf C, Battisti WP, Bridges D, Bruce-Winkler V, Conaty JM, Ellison JM, et al. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330.
43. Lindon JC, Nicholson JK, Holmes E, Keun HC, Craig A, Pearce JTM, et al. Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol 2005;23:833-8. (Pubitemid 43093126)
44. Sung L, Hayden J, Greenberg ML, Koren G, Feldman BM, Tomlinson GA. Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 2005;58:261-8. (Pubitemid 40249468)
45. Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007;96:42-5. (Pubitemid 46080726)
46. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011;119:92-101.
47. From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel. J Infect Dis 1990;161:397-401.
48. Gnekow AK, for the SIOP Brain Tumor Subcommittee, International Society of Pediatric Oncology. Recommendations of the Brain Tumor Subcommittee for the reporting of trials. Med Pediatr Oncol 1995;24:104-8.
49. Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004;45:1416-28. (Pubitemid 39470046)
50. Scher HI, Eisenberger M, D'Amico AV, Halabi S, Small EJ, Morris M, et al. Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 2004;22:537-56. (Pubitemid 41079783)
51. Helmhout PH, Staal JB, Maher CG, Petersen T, Rainville J, Shaw WS. Exercise therapy and low back pain: insights and proposals to improve the design, conduct, and reporting of clinical trials. Spine (Phila Pa 1976) 2008;33:1782-8.
52. Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis 2008;67:1360-4.
53. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-37.
54. Diehm N, Baumgartner I, Jaff M, Do DD, Minar E, Schmidli J, et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J 2007;28:798-805. (Pubitemid 47343592)
55. Nedeltchev K, Pattynama PM, Biaminoo G, Diehm N, Jaff MR, Hopkins LN, et al. Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials. Catheter Cardiovasc Interv 2010;76:333-44.
56. Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP, et al. Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. Am Heart J 2009;158:881-6.
57. Vitek JL, Lyons KE, Bakay R, Benabid AL, Deuschl G, Hallett M, et al. Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD). Mov Disord 2010;25:1530-7.
58. Orchard S, Salwinski L, Kerrien S, Montecchi-Palazzi L, Oesterheld M, Stumpflen V, et al. The minimum information required for reporting a molecular interaction experiment (MIMIx). Nat Biotechnol 2007;25:894-8. (Pubitemid 47236917)
59. Stephenson EL, Braude PR, Mason C. International community consensus standard for reporting derivation of human embryonic stem cell lines. Regen Med 2007;2:349-62. (Pubitemid 47304955)
60. Maxwell KL, Wildes D, Zarrine-Afsar A, De Los Rios MA, Brown AG, Friel CT, et al. Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins. Protein Sci 2005;14:602-16. (Pubitemid 40283898)
61. Deutsch EW, Ball CA, Berman JJ, Bova GS, Brazma A, Bumgarner RE, et al. Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol 2008;26:305-12. (Pubitemid 351355130)
62. Harris RK, Becker ED, Cabral De Menezes SM, Granger P, Hoffman RE, Zilm KW. Further conventions for NMR shielding and chemical shifts IUPAC recommendations 2008. Solid State Nucl Magn Reson 2008;33(3):41-56.
63. Markley JL, Bax A, Arata Y, Hilbers CW, Kaptein R, Sykes BD, et al. Recommendations for the presentation of NMR structures of proteins and nucleic acids: IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy. J Biomol NMR 1998;12(1):1-23. (Pubitemid 128512831)
64. Morton D, Kemp RK, Francke-Carroll S, Jensen K, McCartney J, Monticello TM, et al. Best practices for reporting pathology interpretations within GLP toxicology studies. Toxicol Pathol 2006;34:806-9.
65. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK Jr, Jones AR, et al. The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 2007;25:887-93. (Pubitemid 47236919)
66. Taylor CF, Binz PA, Aebersold R, Affolter M, Barkovich R, Deutsch EW, et al. Guidelines for reporting the use of mass spectrometry in proteomics. Nat Biotechnol 2008;26:860-1.
67. Idris AH, Becker LB, Ornato JP, Hedges JR, Bircher NG, Chandra NC, et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. Circulation 1996;94:2324-36. (Pubitemid 26360548)
68. Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007;4:e296.
69. Tooth L, Ware R, Bain C, Purdie DM, Dobson A. Quality of reporting of observational longitudinal research. Am J Epidemiol 2005;161:280-8. (Pubitemid 40223516)
70. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JPA, Kirsch-Volders M, et al. STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. Eur J Clin Invest 2012;42:1-16.
71. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 2005;41:1690-6. (Pubitemid 41132629)
72. Dixon WG, Carmona L, Finckh A, Hetland ML, Kvien TK, Landewe R, et al. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology. Ann Rheum Dis 2010;69:1596-602.
73. Wolfe F, Lassere M, Van Der Heijde D, Stucki G, Suarez-Almazor M, Pincus T, et al. Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol 1999;26:484-9. (Pubitemid 29066762)
74. Zakrzewska JM, Lopez BC. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery 2003;53:110-20.
75. DeVivo MJ, Biering-Sorensen F, New P, Chen Y. Standardization of data analysis and reporting of results from the International Spinal Cord Injury Core Data Set. Spinal Cord 2011;49:596-9.
76. Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND Statement. Am J Public Health 2004;94:361-6. (Pubitemid 38269486)
77. Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007;7:282-8. (Pubitemid 46420801)
78. Strevel EL, Chau NG, Pond GR, Murgo AJ, Ivy PS, Siu LL. Improving the quality of abstract reporting for phase I cancer trials. Clin Cancer Res 2008;14:1782-7. (Pubitemid 351469464)
79. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
80. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-9. (Pubitemid 46594039)
81. Elliott R, Fischer CT, Rennie DL. Evolving guidelines for publication of qualitative research studies in psychology and related fields. Br J Clin Psychol 1999;38:215-29. (Pubitemid 29435631)
82. Smith L, Rosenzweig L, Schmidt M. Best practices in the reporting of participatory action research: embracing both the forest and the trees. Couns Psychol 2010;38:1115-38.
83. Davidoff F, Batalden P, Stevens D, Ogrinc G, Mooney S, Standards for QUality Improvement Reporting Excellence Development Group. Publication guidelines for quality improvement studies in health care: evolution of the SQUIRE project. J Gen Intern Med 2008;23:2125-30.
84. Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Checklist of information for inclusion in reports of clinical trials. Ann Intern Med 1996;124:741-3.
85. Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994;272:1926-31.
86. Campbell MK, Elbourne DR, Altman DG, for the CONSORT Group. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-8. (Pubitemid 38393415)
87. Campbell MK, Grimshaw JM, Elbourne DR. Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported. BMC Med Res Methodol 2004;4:9.
88. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ, for the CONSORT Group. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement [correction in: JAMA 2006;296:1842]. JAMA 2006;295:1152-60. (Pubitemid 43352345)
89. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet 2008;371:281-3.
90. Krzyzanowska MK, Pintilie M, Brezden-Masley C, Dent R, Tannock IF. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. J Clin Oncol 2004;22:1993-9. (Pubitemid 41095192)
91. Ioannidis JP, Evans SJ, Gotzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781-8. (Pubitemid 39524916)
92. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008;148:W60-6.
93. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C, et al. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144:364-7. (Pubitemid 46768190)
94. Wu T-X, Li Y-P, Bian Z-X, Li T-Q, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) (for solicitation of comments). Chinese Journal of Evidence-Based Medicine 2007;7:625-30. (Pubitemid 47555764)
95. MacPherson H, White A, Cummings M, Jobst KA, Rose K, Niemtzow RC, et al. Standards for Reporting Interventions in Controlled Trials of Acupuncture: the STRICTA recommendations. J Altern Complement Med 2002;8:85-9. (Pubitemid 34174391)
96. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med 2010;7:e1000261
97. Special report: measuring and reporting pain outcomes in randomized controlled trials. Technol Eval Cent Assess Program Exec Summ 2006;21:1-2.
98. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
99. Bousquet PJ, Brozek J, Bachert C, Bieber T, Bonini S, Burney P, et al. The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper. Allergy 2009;64:1737-45.
100. O'Connor AM, Sargeant JM, Gardner IA, Dickson JS, Torrence ME, Consensus MP, et al. The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement. Zoonoses Public Health 2010;57):95-104.
101. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T, et al, for the American Heart Association. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 2002;106:1572-85.
102. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD III, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235:728-39. (Pubitemid 40695866)
103. APA Publications and Communications Board Working Group on Journal Article Reporting Standards. Reporting standards for research in psychology: why do we need them? What might they be? Am Psychol 2008;63:839-51.
104. Howley L, Szauter K, Perkowski L, Clifton M, McNaughton N. Quality of standardised patient research reports in the medical education literature: review and recommendations. Med Educ 2008;42:350-8. (Pubitemid 351388736)
105. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-900.
106. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al, for the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000;283:2008-12. (Pubitemid 30214957)
107. Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hrobjartsson A, et al. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol 2011;64:96-106.
108. Castren M, Karlsten R, Lippert F, Christensen EF, Bovim E, Kvam AM, et al. Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style. Resuscitation 2008;79:193-7.
109. Janssens AC, Ioannidis JP, van Duijn CM, Little J, Khoury MJ, for the GRIPS Group. Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med 2011;8:e1000420.
110. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL, et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002;156:300-10. (Pubitemid 34857997)
111. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. Suggested standards for reports dealing with lower extremity ischemia. J Vasc Surg 1986;4:80-94.
112. Hollander JE, Blomkalns AL, Brogan GX, Diercks DB, Field JM, Garvey JL, et al. Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes. Ann Emerg Med 2004;44:589-98. (Pubitemid 39573176)
113. Horstkotte D, Lengyel M, Mistiaen WP, Piper C, Voller H. Recommendations for reporting morbid events after heart valve surgery. J Heart Valve Dis 2005;14(1):1-7. (Pubitemid 47050760)
114. Landis RC, Murkin JM, Stump DA, Baker RA, Arrowsmith JE, De Somer F, et al. Consensus statement: minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum 2010;13:E116-23.
115. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett PJ, Becker L, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the utstein style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, and Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 1991;84:960-75.
116. Cummins RO, Chamberlain D, Hazinski MF, Nadkarni V, Kloeck W, Kramer E, et al. Recommended guidlines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. Acad Emerg Med 1997;4:603-27. (Pubitemid 27258040)
117. Zaritsky A, Nadkarni V, Hazinski MF, Foltin G, Quan L, Wright J, et al. Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric utstein style. Ann Emerg Med 1995;26:487-503.
118. Langhelle A, Nolan J, Herlitz J, Castren M, Wenzel V, Soreide E, et al. Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style. Resuscitation 2005;66:271-83. (Pubitemid 41222312)
119. Mason EE, Amaral J, Cowan GS Jr, Deitel M, Gleysteen JJ, Oria HE. Standards for reporting results. Obes Surg 1994;4:56-65. (Pubitemid 24063798)
120. Standards Committee, American Society for Bariatric Surgery. Guidelines for reporting results in bariatric surgery. Obes Surg 1997;7:521-2.
121. Benchimol EI, Manuel DG, To T, Griffiths AM, Rabeneck L, Guttmann A. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011;64:821-9.
122. Herman PM, Craig BM, Caspi O. Is complementary and alternative medicine (CAM) cost-effective? A systematic review. BMC Complement Altern Med 2005;5.
123. Jefferson T, Smith R, Yee Y, Drummond M, Pratt M, Gale R. Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and the Lancet. JAMA 1998;280:275-7. (Pubitemid 28493906)
124. Haidich AB, Birtsou C, Dardavessis T, Tirodimos I, Arvanitidou M. The quality of safety reporting in trials is still suboptimal: survey of major general medical journals. J Clin Epidemiol 2011;64:124-35.
125. Turner LA, Singh K, Garritty C, Tsertsvadze A, Manheimer E, Wieland LS, et al. An evaluation of the completeness of safety reporting in reports of complementary and alternative medicine trials. BMC Complement Altern Med 2011;11:67.
126. Lee PE, Fischer HD, Rochon PA, Gill SS, Herrmann N, Bell CM, et al. Published randomized controlled trials of drug therapy for dementia often lack complete data on harm. J Clin Epidemiol 2008;61:1152-60.
127. Ernst E, Hung SK, Clement Y. NCCAM-funded RCTs of herbal medicines: an independent, critical assessment. Perfusion 2011;24:89-102.
128. Hind D, Booth A. Do health technology assessments comply with QUOROM diagram guidance? An empirical study. BMC Med Res Methodol 2007;7:49.
129. Biondi-Zoccai GG, Lotrionte M, Abbate A, Testa L, Remigi E, Burzotta F, et al. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study. BMJ 2006;332:202-6. (Pubitemid 43171699)
130. Poolman RW, Abouali JA, Conter HJ, Bhandari M. Overlapping systematic reviews of anterior cruciate ligament reconstruction comparing hamstring autograft with bone-patellar tendon-bone autograft: why are they different? J Bone Joint Surg Am 2007;89:1542-52. (Pubitemid 47041532)
131. Freeman K, Szczepura A, Osipenko L. Non-invasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol 2009;142:91-8.
132. Mahoney J, Ellison J. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Clin Chem 2007;53:1122-8. (Pubitemid 46867530)
133. Selman TJ, Morris RK, Zamora J, Khan KS. The quality of reporting of primary test accuracy studies in obstetrics and gynaecology: application of the STARD criteria. BMC Womens Health 2011;11:8.
134. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Bossuyt PM, Reitsma JB, et al. The quality of diagnostic accuracy studies since the STARD statement: has it improved? Neurology 2006;67:792-7. (Pubitemid 44394191)
135. Coppus SF, van der Veen F, Bossuyt PM, Mol BW. Quality of reporting of test accuracy studies in reproductive medicine: impact of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative. Fertil Steril 2006;86:1321-9. (Pubitemid 44602037)
136. Johnson ZK, Siddiqui MA, Azuara-Blanco A. The quality of reporting of diagnostic accuracy studies of optical coherence tomography in glaucoma. Ophthalmology 2007;114:1607-12. (Pubitemid 47332663)
137. Krzych LJ, Liszka L. No improvement in studies reporting the diagnostic accuracy of B-type natriuretic peptide. Med Sci Monit 2009;15:SR5-14.
138. Paranjothy B, Shunmugam M, Azuara-Blanco A. The quality of reporting of diagnostic accuracy studies in glaucoma using scanning laser polarimetry. J Glaucoma 2007;16:670-5. (Pubitemid 350307627)
139. Hammerschlag R, Milley R, Colbert A, Weih J, Yohalem-Ilsley B, Mist S, et al. Randomized controlled trials of acupuncture (1997-2007): an assessment of reporting quality with a CONSORT- and STRICTA-based instrument. Evid Based Complement Alternat Med 2011;2011:pii:183910.
140. Delaney M, Meyer E, Cserti-Gazdewich C, Haspel RL, Lin Y, Morris A, et al. A systematic assessment of the quality of reporting for platelet transfusion studies. Transfusion 2010;50:2135-44.
141. Peron J, Maillet D, Gan HK, Chen EX, You B. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review. J Clin Oncol 2013;31:3957-63.
142. Cornelius VR, Sauzet O, Williams JE, Ayis S, Farquhar-Smith P, Ross JR, et al. Adverse event reporting in randomised controlled trials of neuropathic pain: considerations for future practice. Pain 2013;154:213-20.
143. Tunis AS, McInnes MD, Hanna R, Esmail K. Association of study quality with completeness of reporting: have completeness of reporting and quality of systematic reviews and meta-analyses in major radiology journals changed since publication of the PRISMA statement? Radiology 2013;269:413-26.
144. Fleming PS, Seehra J, Polychronopoulou A, Fedorowicz Z, Pandis N. A PRISMA assessment of the reporting quality of systematic reviews in orthodontics. Angle Orthod 2013;83:158-63.
145. Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S. Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. Plos One 2013;8:e83138.
146. Ghimire S, Kyung E, Lee H, Kim E. Oncology trial abstracts showed suboptimal improvement in reporting: a comparative before-and-after evaluation using CONSORT for Abstract guidelines. J Clin Epidemiol 2014;67:658-66.
147. Parsons NR, Hiskens R, Price CL, Achten J, Costa ML. A systematic survey of the quality of research reporting in general orthopaedic journals. J Bone Joint Surg Br 2011;93:1154-9.
148. Faggion CM Jr, Tu YK, Giannakopoulos NN. Reporting adverse events in randomized controlled trials in periodontology: a systematic review. J Clin Periodontol 2013;40:889-95.
149. Kim KH, Kang JW, Lee MS, Lee JD. Assessment of the quality of reporting for treatment components in Cochrane reviews of acupuncture. BMJ Open 2014;4:e004136.
150. Bastuji-Garin S, Sbidian E, Gaudy-Marqueste C, Ferrat E, Roujeau JC, Richard MA, et al. Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis. Plos One 2013;8:e64733.
151. Hodkinson A, Kirkham JJ, Tudur-Smith C, Gamble C. Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension. BMJ Open 2013;3:e003436.
152. Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 2005;330:1056-7. (Pubitemid 40646557)
153. Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials 2008;9:20.
154. Smidt N, Overbeke J, De VH, Bossuyt P. Endorsement of the STARD Statement by biomedical journals: survey of instructions for authors. Clin Chem 2007;53:1983-5. (Pubitemid 350036050)
155. Meerpohl JJ, Wolff RF, Niemeyer CM, Antes G, von Elm E. Editorial policies of pediatric journals: survey of instructions for authors. Arch Pediatr Adolesc Med 2010;164:268-72.
156. Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. Plos One 2012;7:e35621.
157. Shamseer L, Theilman J, Turner L, Hopewell S, Altman DG, Schulz KF, et al. Update on the endorsement of CONSORT by high impact factor journals: a survey of journal editors and instructions to authors. Seventh International Congress on Peer Review and Biomedical Publication, Chicago, USA, September 8-10, 2013.
158. Cobo E, Cortes J, Ribera JM, Cardellach F, Selva-O'Callaghan A, Kostov B, et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ 2011;343:d6783.
159. Canadian Institutes of Health Research. About knowledge translation. 2014. www.cihrirsc.gc.ca/e/29418.html.
160. Improved Clinical Effectiveness through Behavioural Research Group (ICEBeRG). Designing theoretically-informed implementation interventions. Implement Sci 2006;1:4.
161. French SD, Green SE, O'Connor DA, McKenzie JE, Francis JJ, Michie S, et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework. Implement Sci 2012;7:38.
162. Fleming PS, Seehra J, Polychronopoulou A, Fedorowicz Z, Pandis N. Cochrane and non-Cochrane systematic reviews in leading orthodontic journals: a quality paradigm? Eur J Orthod 2013;35:244-8.